$423.55
0.87% yesterday
NYSE, May 02, 10:10 pm CET
ISIN
US8835561023
Symbol
TMO

Thermo Fisher Scientific Stock price

$423.55
-65.51 13.40% 1M
-131.92 23.75% 6M
-96.68 18.58% YTD
-147.70 25.86% 1Y
-121.97 22.36% 3Y
+96.83 29.64% 5Y
+295.77 231.47% 10Y
NYSE, Closing price Fri, May 02 2025
+3.66 0.87%
ISIN
US8835561023
Symbol
TMO
Sector

Key metrics

Market capitalization $159.89b
Enterprise Value $188.26b
P/E (TTM) P/E ratio 24.85
EV/FCF (TTM) EV/FCF 28.00
EV/Sales (TTM) EV/Sales 4.39
P/S ratio (TTM) P/S ratio 3.73
P/B ratio (TTM) P/B ratio 3.25
Dividend yield 0.37%
Last dividend (FY24) $1.56
Revenue growth (TTM) Revenue growth 0.96%
Revenue (TTM) Revenue $42.90b
EBIT (operating result TTM) EBIT $7.76b
Free Cash Flow (TTM) Free Cash Flow $6.72b
Cash position $5.95b
EPS (TTM) EPS $17.04
P/E forward 23.75
P/S forward 3.66
EV/Sales forward 4.31
Short interest 1.27%
Show more

Is Thermo Fisher Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,786 stocks worldwide.

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

27x Buy
84%
5x Hold
16%

Analyst Opinions

32 Analysts have issued a Thermo Fisher Scientific forecast:

Buy
84%
Hold
16%

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
42,898 42,898
1% 1%
100%
- Direct Costs 25,865 25,865
1% 1%
60%
17,033 17,033
2% 2%
40%
- Selling and Administrative Expenses 4,896 4,896
6% 6%
11%
- Research and Development Expense 1,401 1,401
6% 6%
3%
10,736 10,736
1% 1%
25%
- Depreciation and Amortization 2,978 2,978
12% 12%
7%
EBIT (Operating Income) EBIT 7,758 7,758
4% 4%
18%
Net Profit 6,523 6,523
8% 8%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Thermo Fisher Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Thermo Fisher Scientific Stock News

Positive
Seeking Alpha
3 days ago
Geopolitical risks and economic uncertainty have battered markets, but I view this turmoil as an opportunity to buy high-quality, undervalued stocks. Despite volatility and weak earnings trends, I'm focused on companies trading well below fair value, with strong fundamentals and long-term growth potential. In this article, I highlight three dirt-cheap stocks across different industries that I b...
Positive
Seeking Alpha
4 days ago
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetr...
Neutral
Business Wire
5 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months, helping biotech and pharmaceutical companies overcome logistical complexities within pre-clinical biologic drug development. The new CHO ...
More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office United States
CEO Marc Casper
Employees 125,000
Founded 1960
Website www.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today